Month: January 2026

New Taipei City, Taiwan, Jan. 30, 2026 (GLOBE NEWSWIRE) — Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced updated statistical analyses for key blood biochemical markers from its Phase II clinical trial of MCS-8 (PCP) conducted in Taiwan. The results underscore MCS-8’s previously indicated multifaceted clinical and commercial potential beyond its clinical evidence in prostate cancer prevention, showing its potential in helping alleviate high-grade malignancy risk. The data reveals significant new value in metabolic...

BAYONNE, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) — BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported a net loss of $12.0 million for the fourth quarter of 2025, compared to net income of $4.3 million in the third quarter of 2025, and net income of $3.3 million for the fourth quarter of 2024. The Company’s loss per diluted share for the fourth quarter was ($0.73) compared to earnings per diluted share of $0.22 in the preceding quarter and $0.16 in the fourth quarter of 2024. The Company also announced that its Board of Directors has declared a regular quarterly cash dividend of $0.08 per share. The dividend will be payable on February 26, 2026, to common shareholders of record on February 11, 2026. “As previously noted in our Form 8-K filed on January 16, 2026,...

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its fourth quarter and full year 2025 financial results on Wednesday, February 11, 2026 at 10:00 a.m. Eastern Time. The Company’s fourth quarter and full year 2025 financial results will be released after the market closes on Tuesday, February 10, 2026. During the conference call, Company officers will review fourth quarter and full year 2025 performance, discuss recent events and conduct a question-and-answer period. To register for the call, please use the following link:  https://register-conf.media-server.com/register/BI38479ef1e3ec49b4b441a21cb7cb9b63 After you register, you will receive a dial-in number and unique pin. The Company will...

Follow-on order of approximately $150,000 validates Actelis’ solution and demonstrates growing adoption in energy sector; deployment supports homeland security objectives through modernization of critical infrastructure monitoring and cyber-hardened connectivity SUNNYVALE, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has received an expansion order of approximately $150,000 from the major European natural gas transmission system operator with whom it announced its initial deployment in October 2023. This significant follow-on order demonstrates customer satisfaction and further validates Actelis’ technology...

WISeSat.Space Brought Together Global Thought-Leaders to Davos to Address Quantum Security in Space Watch the entire roundtable discussion here: https://youtu.be/YDKj1nxbPdoDavos, Switzerland – January 30, 2026 – WISeKey International Holding Ltd (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, blockchain, and IoT company, today announced that during its Quantum Security Space Roundtable, held as part of the WISeKey Davos 2026 program, brought together thought-leaders from a variety of industries including defense, space, quantum technologies, and cybersecurity, to address one of the most urgent challenges facing the space sector: securing space infrastructure in the post-quantum era. As quantum computing advances, traditional cryptographic systems such as RSA and ECC will become vulnerable, placing satellite communications,...

VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care NEW YORK and STRONGSVILLE, Ohio, Jan. 30, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), today announced VIO Med Spa as a launch partner for the Aesthetics Leadership with Obagi’s Hyaluronic Acid (ALOHA) Program. VIO Med Spa was selected for its rapid growth, expert-led approach to advanced aesthetic treatments, and dedication to delivering high-quality, results-driven care across its expanding national network of locations. Through this real-world evaluation collaboration, VIO Med Spa will conduct a structured, multi-site assessment of Obagi®...

Expanded Distribution Builds on Existing Relationship and Strengthens Regional Retail Presence BELVIDERE, NJ, Jan. 30, 2026 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that its Gourmet Greens Hydroponic Basil is now available at Hannaford Supermarkets. The launch expands the Company’s branded product offerings within the retailer and builds on an established relationship focused on freshness, quality, and operational efficiency. Gourmet Greens is a distinct brand within Edible Garden’s portfolio, offering consumers premium hydroponically grown basil cultivated using the Company’s proprietary growing systems and sustainability-driven...

STAMFORD, Conn., Jan. 30, 2026 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE: SGU), a leading home energy distributor and services provider, today announced that it will release its fiscal 2026 first quarter results after the close of trading on February 4, 2026. Members of Star’s management team will host a webcast and conference call at 11:00 a.m. Eastern Time the following day, February 5, 2026, to review the three months ended December 31, 2025. The webcast will be accessible on the company’s website, at www.stargrouplp.com, and the telephone number for the conference call is 888-346-3470 (412-317-5169 for international callers). About Star Group, L.P.Star Group, L.P. is a full service provider specializing in the sale of home heating products and services to residential and commercial customers...

– Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer – – Full data set submitted for presentation at an upcoming scientific conference – SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, announced new data from a Phase 1b/2 clinical trial evaluating the company’s investigational CD47-inhibitor evorpacept in combination with Jazz Pharmaceuticals’ ZIIHERA® (zanidatamab-hrii) in heavily pretreated patients with metastatic breast cancer (mBC). The topline findings, from an exploratory...